The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|August 18, 2017
Supplements and Featured Publications
- Exclusive Coverage of the 2017 AMERICAN DIABETES ASSOCIATION 77TH SCIENTIFIC SESSIONS
Exclusive Coverage of the 2017 AMERICAN DIABETES ASSOCIATION 77TH SCIENTIFIC SESSIONS
Highlights from the American Diabetes Association 77th Scientific Sessions, which took place on June 9-13, 2017 in San Diego, CA are available in this newsletter published by The American Journal of Managed Care.
Advertisement
Advertisement
Related to this article
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
Advertisement
Advertisement
Trending on AJMC
1
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
2
The Liver Meeting 2026 Highlights Hepatitis Delta, PBC Targets, MASH Costs
3
AHIP's Jeanette Thornton on Prior Authorization Reform, Midterms
4
US Measles Outbreaks Cost Nearly $83 Million in 2026
5